November marks Diabetes Awareness Month, and Dr. Elizabeth Gersh is shedding light on the crucial differences between type 1 ...

The word “diabetes” serves as an umbrella term covering conditions that share a common symptom—elevated blood sugar—but diverge significantly in their underlying mechanisms, progression patterns, and ...

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent ...